DWC 3.0 situation 2017
DWC 3.0 is listed at the Euronext Paris “Marche Libre”since the 27th of April 2016 with the issuing price at 0.65 euros.On the 23rd of December 2016, the board , in the interest of the share holders, decided to suspend the trading of DWC 3.0 due to a suspected downward manipulation of the share price.In absence of any proof, with regards to the above mentioned , DWC 3.0 requested and obtained the re-opening of trading of the shares on the 20th of March2017. During this suspension lapse, the Company carried on its industrial plan in total transperancy in order to update the market as well as the share holders.On the 3rd of december 2016, a capital increase of 8,204,999,52 euros for a total number of 22,791,669 new ordinary shares no par value as per the 21st december 2016 subscription with referance to an increaseed capital deliberation of 50 Million Euros, approved on the 4th of november 2015.
On the 21st december 2016, the fully paid capital of DWC 3.0 therefore amounted to 10,383,027,93 for a total of 36,019,698 issued shares at no par value. The asset value of the Company on the 31st of December 2016 is represented by assets in specific sectors as per its industrial strategy plan.
The Company considers of foremost importance, its presence within the Fine Art sector , forecasting a positive trend in a near-future.As estimated by the Merrill Lynch -Cap Gemini, the world investments are likely to grow steadily.Currently, the global investments amounts to beyond 1300 Billions of dollars corresponding to a little more than 3 percent of the total assets of the richest people on earth.
The other sectors in which DWC 3.0 has decided to concentrate upon are as follows: Real Estate, especially tourism, resorts,restaurants etc Minority share holding of Private and Public Companies as Pharmaceutical, Medical, Biotechnology Soft ware for tablets and smart phones. In these latter areas, the company is considering various possibilities of new investments.
The geographical areas in which the Company is evaluating and negociating with are India with three Biotech projects North America with two:
a) Software Company
b) Pharmaceutical Company
The investment on the 21st December 2016 amounts to 12,8 Million Euros. DWC 3.0 has reached the expected results on the asset plan approved in a three year forecast for a total capital investment of 13 Million Euros. By the 31st of December 2018, the target stakes in minority share holding has been set by the Board as per the forecast for a global value of 100 Million Euros. As far as the commercial developments are concerned, the Board will commence the required procedure for the listing of the Company before the 31st of December 2017 at the Euronext Alternext Market.